Gastrointestinal symptoms in idiopathic pulmonary fibrosis patients treated with pirfenidone and herbal medicine.

Abstract

Pirfenidone is an antifibrotic agent for patients with pulmonary fibrosis, but this drug has adverse gastrointestinal (GI) effects. The first aim of this study was to assess GI symptoms due to pirfenidone by using a new questionnaire for reflux symptoms and dismotility symptoms. Whether adding herbal medicine of rikkunshi-to improved GI symptoms due to pirfenidone therapy was also investigated. This was a randomized controlled trial performed on 17 IPF patients. The patients were assigned to two groups, and the study period was 8 weeks. The pirfenidone group received pirfenidone therapy for 8 weeks with add-on rikkunshi-to from 4 weeks, while the control group did not receive either of these agents. To assess the effects of RK, plasma levels of acyl-ghrelin and des-acyl-ghrelin, serum KL-6 and surfactant protein-D, and pulmonary function tests were monitored. GI symptoms were most severe during the initial 2 weeks of pirfenidone therapy at a dose of 600 mg/day. Both reflux symptoms and dismotility symptoms deteriorated. Rikkunshi-to improved GI symptoms to the level prior to pirfenidone therapy. Plasma levels of des-acyl-ghrelin and acyl-/des-acyl-ghrelin ratio changed significantly at 8 weeks compared to 2 weeks. GI adverse events due to PFD were most severe in the first 2 weeks of treatment at a dose of 600 mg/day, and both reflux and dismotility symptoms deteriorated, but the drug was well tolerated at 1200 mg/day. Rikkunshi-to contributed to improvement of GI symptoms, but plasma ghrelin levels did not reflect the improvement of GI symptoms.

• Authors: Y Shimizu, Y Shimoyama, A Kawada, M Kusano, Y Hosomi, M Sekiguchi, T Kawata, T Horie, Y Ishii, M Yamada, K Dobashi, A Takise
• Journal: Journal of biological regulators and homeostatic agents (J Biol Regul Homeost Agents) 2014 Jul-Sep Vol. 28 Issue 3 Pg. 433-42 ISSN: 0393-974X [Print] Italy
• PMID: 25316130 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Drugs, Chinese Herbal
• Ghrelin
• MUC1 protein, human
• Mucin-1
• Pyridones
• ghrelin, des-n-octanoyl
• liu-jun-zi-tang
• pirfenidone

Topics

• Aged
• Aged, 80 and over
• Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, adverse effects)
• Drugs, Chinese Herbal (administration & dosage, adverse effects)
• Female
• Gastroesophageal Reflux (blood, chemically induced, physiopathology)
• Ghrelin (blood)
• Humans
• Idiopathic Pulmonary Fibrosis (blood, drug therapy, physiopathology)
• Male
• Middle Aged
• Mucin-1 (blood)
• Pyridones (administration & dosage, adverse effects)
• Surveys and Questionnaires
• Time Factors